State

Nebraska product recalls

73,833 recalls have nationwide distribution and so reach Nebraska. 4,580 additional recalls listed Nebraska specifically in their distribution scope.

What the numbers show

Total: 4,580
Critical: 713
Severe: 1,345
Most recent: 2026-10-28

Of the 4,580 recalls naming Nebraska we have scored against our rubric, 713 (16%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,345 (29%) are Severe.

Which agencies issued them

These figures cover only the 4,580 recalls whose distribution notice names Nebraska specifically. The 73,833 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

57876–57900 of 78413

SevereFDA (Drugs)·D-842-2015·2015-04-29
Attix Pharmaceuticals Recalls Pimecrolimus Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Pimecrolimus active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Pimecrolimus active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-678-2015·2015-04-29
Attix Pharmaceuticals Recalls Flucytosine Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Flucytosine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Flucytosine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-888-2015·2015-04-29
Secnidazole API Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling Secnidazole active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Secnidazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-600-2015·2015-04-29
Attix Pharmaceuticals Recalls Cortisone Acetate Micronized Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Cortisone Acetate Micronized active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Cortisone Acetate Micronized active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-745-2015·2015-04-29
Attix Pharmaceuticals Recalls L-Asparaginase Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling L-Asparaginase active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
L-Asparaginase active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-682-2015·2015-04-29
Fluorescein Sodium Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Fluorescein Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Fluorescein Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-949-2015·2015-04-29
Vancomycin HCl Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Vancomycin HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Vancomycin HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-704-2015·2015-04-29
Attix Pharmaceuticals Recalls Heptaminol Hydrochloride Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Heptaminol Hydrochloride active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Heptaminol Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-775-2015·2015-04-29
Attix Pharmaceuticals Recalls Mefloquine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Mefloquine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Mefloquine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-555-2015·2015-04-29
Attix Pharmaceuticals Recalls Calcipotriene Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Calcipotriene active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Calcipotriene active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-590-2015·2015-04-29
Attix Pharmaceuticals Recalls Cisplatin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling cisplatin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Cisplatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-891-2015·2015-04-29
Sertraline HCl Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Sertraline HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Sertraline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-832-2015·2015-04-29
Attix Pharmaceuticals Recalls Paromomycin Sulphate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Paromomycin Sulphate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Paromomycin Sulphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-672-2015·2015-04-29
Attix Pharmaceuticals Recalls Famotidine API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling famotidine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Famotidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-922-2015·2015-04-29
Attix Pharmaceuticals Recalls Tetracaine Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tetracaine (free base) active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Tetracaine (free base) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-497-2015·2015-04-29
Attix Pharmaceuticals Recalls 5-Fluorouracil Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling 5-Fluorouracil active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
5-Fluorouracil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-498-2015·2015-04-29
Attix Pharmaceuticals Recalls 2-Methoxyestradiol Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling 2-Methoxyestradiol active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
2-Methoxyestradiol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-925-2015·2015-04-29
Attix Pharmaceuticals Recalls Theophylline Anhydrous Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Theophylline Anhydrous active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Theophylline Anhydrous active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-691-2015·2015-04-29
Attix Pharmaceuticals Recalls Formestane API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Formestane active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Formestane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-701-2015·2015-04-29
Attix Pharmaceuticals Recalls Guanabenz Acetate Due to Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Guanabenz Acetate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Guanabenz Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-681-2015·2015-04-29
Attix Pharmaceuticals Recalls Flunarizine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Flunarizine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Flunarizine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereUSDA FSIS·071-2015·2015-04-29
Golden Krust Patties Recalls Beef and Chicken Products for Undeclared Egg
Golden Krust Patties is recalling approximately 9 million pounds of beef and chicken products because they contain egg, a known allergen, that is not declared on the label.
Product
Golden Krust Patties Inc. — Golden Krust Patties Recalls Beef and Chicken Products Due To Misbranding and Undeclared Allergens
Category
Food
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-924-2015·2015-04-29
Attix Pharmaceuticals Recalls Tetracycline HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tetracycline HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Tetracycline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-646-2015·2015-04-29
Attix Pharmaceuticals Recalls Duloxetine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Duloxetine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Duloxetine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-662-2015·2015-04-29
Attix Pharmaceuticals Recalls Ethopropazine HCI Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Ethopropazine HCI active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Ethopropazine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide